Will 2023 be the Year of Cathie Wood ETFs?
Cathie Wood, famous for the success of Ark Investment's winning products, had faced a miserable fate in 2022. Will her ETFs see success in 2023?
Pharma & Biotech ETFs at One-Month High: Here's Why
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.
Is ARK's Stellar Run Over? 5 ETF Themes to Follow Cathie Wood
Though Cathie Wood's Ark Investment's star products underperformed in 2021 and may continue to lag the broader market in 2022, Wood's fans may follow these ETF strategies to capitalize on her vision.